Key indicators: single-crystal X-ray study; T = 120 K; mean (C-C) = 0.008 Å; disorder in main residue; R factor = 0.047; wR factor = 0.156; data-to-parameter ratio = 10.9.
The title compound, C 11 H 12 ClN 3 O 2 , is essentially planar except for the n-butoxy group [r.m.s. deviation from the least-squares plane = 0.0131 (1) Å for 11 non-H atoms]. An intramolecular N-HÁ Á ÁO interaction results in the formation of an S(6) ring. The n-butoxy chain in the molecule is disordered over two sets of sites of equal occupancy.
Related literature
For applications of this class of compounds, see: Matter et al. (2005) ; Kaliszan et al. (1985) ; Petrusewicz et al. (1992 Petrusewicz et al. ( , 1993 Petrusewicz et al. ( , 1995 . For pyrazinyl-pyrazylidene tautomerism, see: Pilarski et al. (1984) . For related structures, see: Vishweshwar et al. (2000) ; Wardell et al. (2006) . For the synthesis, see: Pilarski & Foks (1981 , 1982 .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). (Petrusewicz et al., 1995 ), analgesic (Kaliszan et al., 1985 and large number of other pharmacological activities (Petrusewicz et al., 1992) . Numerous scientific publications confirm that pyrazine derivatives, obtained by nucleophilic substitution of chlorine atom in the pyrazine ring system with active methylene compound, posses above mentioned activity. Some of pyrazine C-H and N-H acids also demonstrated antithrombotic and antiplatelet activity (Petrusewicz et al., 1993) .
Such pharmacological activity (in group CH-andNH-acids) is possibly the result of acid character of particle and their structure, as in case of well known inhibitors of cyclooxygenase (Petrusewicz et al., 1993) . Structural analysis of pyrazine-acetonitrile derivatives shows pyrazinyl-pyrazylidene tautomerism (Pilarski et al., 1984) but crystal of 2-butyl
In the molecule of the title compound ( An intramolecular N2-H2B···O1 contact generates a S(6) ring motif which stabilizes the molecular conformation. The n-butoxy chain in the molecule is disordered over two sets of sites in a 0.50 (1):0.50 (1) ratio.
Experimental 2-butyl 2-(3-chloropyrazin-2(1H)-ylidene)-2-cyanoacetate was obtained bygeneral method described in papers (Pilarski et al., 1981; Pilarski et al., 1982) . Crystallization of this compound from methanol forms a crystal.
Refinement
Atoms O2, C8 (H8A, H8B), C9 (H9A, H9B), C10 (H10A, H10B), C11 (H11A, H11B, H11C) were disordered over two positions. During the refinement process the disordered atoms were refined with occupancies of 0.50 and 0.50. H atoms bonded to C were included in calculated positions and refined as riding on their parent C atom with C-H = 0.95 Å U iso (H) = 1.2 U eq (C) for aromatic, C-H = 0.99 Å U iso (H) = 1.2 U eq (C) for methylene and C-H = 0.98 Å U iso (H) = 1.5 U eq (C) for methyl H atoms. The H2B atom was located from difference Fourier map and refined isotropically resulting in N-H abond length 0.87 (2) Å U iso (H) = 0.10 (2) Å 2 . The carbon atoms C8, C9, C10, C11 and C8A, C9A, C10A, C11A were located from a difference map, fixed at 1.50 for C-C distance and refined with the DFIX restraint. The Flack (1983) parameter was refined explicity, with both TWIN and BASF parameters.
sup-2 Figures   Fig. 1 . The moleculare structure of the title compound showing the atomic numbering scheme. Displacement ellipsoids are drawn at the 50% probability level.
n-Butyl 2-(3-chloro-1,2-dihydropyrazin-2-ylidene)-2-cyanoacetate
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